-
1
-
-
0033808223
-
The relationship between control of intraocular pressure and visual field deterioration. The AGIS investigators
-
The Advanced Glaucoma Intervention Study (AGIS): 7
-
The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am. J. Ophthalmol. 130:429-440, 2000.
-
(2000)
Am. J. Ophthalmol.
, vol.130
, pp. 429-440
-
-
-
2
-
-
0037251618
-
Factors for glaucoma progression and the effect of treatment: The early manifest glaucoma trial
-
Leske, M.C., Heijl, A., Hussein, M., et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch. Ophthalmol. 121:48-56, 2003. (Pubitemid 36401765)
-
(2003)
Archives of Ophthalmology
, vol.121
, Issue.1
, pp. 48-56
-
-
Leske, M.C.1
Heijl, A.2
Hussein, M.3
Bengtsson, B.4
Hyman, L.5
Komaroff, E.6
-
3
-
-
80051897270
-
Intraocular pressure control and long-term visual field loss in the collaborative initial glaucoma treatment study
-
Musch, D.C., Gillespie, B.W., Niziol, L.M., Lichter, P.R., and Varma, R. Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology 118:1766-1773, 2011.
-
(2011)
Ophthalmology
, vol.118
, pp. 1766-1773
-
-
Musch, D.C.1
Gillespie, B.W.2
Niziol, L.M.3
Lichter, P.R.4
Varma, R.5
-
4
-
-
0036269833
-
The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma
-
Kass, M.A., Heuer, D.K., Higginbotham, E.J., et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch. Ophthalmol. 120:701-713, 2002. (Pubitemid 34620348)
-
(2002)
Archives of Ophthalmology
, vol.120
, Issue.6
, pp. 701-713
-
-
Kass, M.A.1
Heuer, D.K.2
Higginbotham, E.J.3
Johnson, C.A.4
Keltner, J.L.5
Philip Miller, J.6
Parrish II, R.K.7
Roy Wilson, M.8
Gordon, M.O.9
-
5
-
-
77749330689
-
Delaying treatment of ocular hypertension: The ocular hypertension treatment study
-
Kass, M.A., Gordon, M.O., Gao, F., et al. Delaying treatment of ocular hypertension: the ocular hypertension treatment study. Arch. Ophthalmol. 128:276-287, 2010.
-
(2010)
Arch. Ophthalmol.
, vol.128
, pp. 276-287
-
-
Kass, M.A.1
Gordon, M.O.2
Gao, F.3
-
6
-
-
0015947313
-
Drop size and initial dosing frequency problems of topically applied ophthalmic drugs
-
Chrai, S.S., Makoid, M.C., Eriksen, S.P., and Robinson, J.R. Drop size and initial dosing frequency problems of topically applied ophthalmic drugs. J. Pharm. Sci. 63:333-338, 1974.
-
(1974)
J. Pharm. Sci.
, vol.63
, pp. 333-338
-
-
Chrai, S.S.1
Makoid, M.C.2
Eriksen, S.P.3
Robinson, J.R.4
-
7
-
-
34447129594
-
Ocular symptoms and signs with preserved and preservative-free glaucoma medications
-
Jaenen, N., Baudouin, C., Pouliquen, P., et al. Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur. J. Ophthalmol. 17:341-349, 2007. (Pubitemid 47056287)
-
(2007)
European Journal of Ophthalmology
, vol.17
, Issue.3
, pp. 341-349
-
-
Jaenen, N.1
Baudouin, C.2
Pouliquen, P.3
Manni, G.4
Figueiredo, A.5
Zeyen, T.6
-
8
-
-
0036222151
-
Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication
-
DOI 10.1136/bjo.86.4.418
-
Pisella, P.J., Pouliquen, P., and Baudouin, C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br. J. Ophthalmol. 86:418-423, 2002. (Pubitemid 34293291)
-
(2002)
British Journal of Ophthalmology
, vol.86
, Issue.4
, pp. 418-423
-
-
Pisella, P.J.1
Pouliquen, P.2
Baudouin, C.3
-
10
-
-
69249214004
-
Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs
-
Bournias, T.E., and Lai, J. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs. Ophthalmology 116:1719-1724, 2009.
-
(2009)
Ophthalmology
, vol.116
, pp. 1719-1724
-
-
Bournias, T.E.1
Lai, J.2
-
11
-
-
44349161663
-
Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension
-
DOI 10.1185/030079908X301848
-
Day, D.G., and Hollander, D.A. Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension. Curr. Med. Res. Opin. 24:1435-1442, 2008. (Pubitemid 351741577)
-
(2008)
Current Medical Research and Opinion
, vol.24
, Issue.5
, pp. 1435-1442
-
-
Day, D.G.1
Hollander, D.A.2
-
12
-
-
33646864300
-
A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension
-
DOI 10.1016/j.clinthera.2006.04.007, PII S0149291806000956
-
Reis, R., Queiroz, C.F., Santos, L.C., Avila, M.P., and Magacho, L. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension. Clin. Ther. 28:552-559, 2006. (Pubitemid 43783448)
-
(2006)
Clinical Therapeutics
, vol.28
, Issue.4
, pp. 552-559
-
-
Reis, R.1
Queiroz, C.F.2
Santos, L.C.3
Avila, M.P.4
Magacho, L.5
-
13
-
-
0032169810
-
Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension
-
Brinzolamide Primary Therapy Study Group
-
Silver, L.H. Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group. Am. J. Ophthalmol. 126:400-408, 1998.
-
(1998)
Am. J. Ophthalmol.
, vol.126
, pp. 400-408
-
-
Silver, L.H.1
-
14
-
-
0034056845
-
The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension
-
Brinzolamide Primary Therapy Study Group
-
Sall, K. The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension. Brinzolamide Primary Therapy Study Group. Surv. Ophthalmol. 44 Suppl 2:S155-S162, 2000.
-
(2000)
Surv. Ophthalmol.
, vol.44
, Issue.SUPPL. 2
-
-
Sall, K.1
-
15
-
-
23944477451
-
Brimonidine and timolol fixed-combination therapy versus monotherapy: A 3-month randomized trial in patients with glaucoma or ocular hypertension
-
DOI 10.1089/jop.2005.21.337
-
Craven, E.R., Walters, T.R., Williams, R., et al. Brimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertension. J. Ocul. Pharmacol. Ther. 21:337-348, 2005. (Pubitemid 41192905)
-
(2005)
Journal of Ocular Pharmacology and Therapeutics
, vol.21
, Issue.4
, pp. 337-348
-
-
Craven, E.R.1
Walters, T.R.2
Williams, R.3
Chou, C.4
Cheetham, J.K.5
Schiffman, R.6
-
16
-
-
0033859558
-
Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure
-
DOI 10.1016/S0002-9394(00)00381-0, PII S0002939400003810
-
Stewart, W.C., Sharpe, E.D., Harbin, T.S., Jr., et al. Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure. Am. J. Ophthalmol. 129:723-727, 2000. (Pubitemid 30604149)
-
(2000)
American Journal of Ophthalmology
, vol.129
, Issue.6
, pp. 723-727
-
-
Stewart, W.C.1
Sharpe, E.D.2
Harbin Jr., T.S.3
Pastor, S.A.4
Day, D.G.5
Holmes, K.T.6
Stewart, J.A.7
|